RYAN VISBEEN: Open Payments
NPI 1376179283 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$981 in 41 payments from 13 companies in 2025. Trend: 2023 $634 · 2024 $987 · 2025 $981
Food & beverage: $970Education: $12
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 10 | $194 |
| Travere Therapeutics, Inc. | 9 | $161 |
| Amgen Inc. | 1 | $150 |
| Novartis Pharmaceuticals Corporation | 5 | $91 |
| Novo Nordisk Inc | 3 | $88 |
| AstraZeneca Pharmaceuticals LP | 5 | $87 |
| Janssen Biotech, Inc. | 1 | $76 |
| Renalytix AI, Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Calliditas Therapeutics US Inc. | 1 | $23 |
Products named: VELPHORO, FARXIGA, TALVEY, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT, Ozempic, Kerendia, Wegovy, TARPEYO.
Industry payments across NJ — which companies pay providers there.
